Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

We recently published an article titled These 10 Firms Led This Week’s Rally. In this article, we are going to take a look at ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from William Blair analyst Margaret Kaczor today. The ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research note released on Tuesday morning,Zacks.com reports. Several other equities ...

Inari Medical was founded in 2011 and focuses on the treatment of venous thromboembolism, which impacts up to 900,000 people per year in the United States. “With Stryker’s capabilities and ...

1 People are at particularly high risk for this condition during or just after a hospitalization (with or without surgery), during cancer treatment and during or just after pregnancy. 1 Inari provides ...

It is also called colorectal cancer.. Your treatment depends on whether you have colon or rectal cancer. Your treatment also depends on a number of factors including how far the cancer has grown, ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral. Analyst Price Forecast Suggests 14.00% Downside As of December 23, 2024, ...

Towards the end of life, you might want to make decisions about your care. This includes any instructions for refusing treatment. It can sometimes be very difficult to know what care and treatment to ...

Inari shareholders are getting a fair price ... with a primary focus on stroke and aneurysm treatment including coils, catheters, microcatheters, stents, and mechanical thrombectomy devices.